Clinical Trials Logo

Clinical Trial Summary

Cataract surgery is one of the most frequently performed surgical procedures worldwide. Since the introduction of phacoemulsification to remove the cataractous lens, risk and complication rates of cataract surgery decreased significantly.

The phacoemulsification technique utilizes a high-intensity ultrasound energy for the fragmentation and emulsification of the lens. One of the main complications during phacoemulsification, is damaging of the endothelium due to contact with lens fragments of the nucleus following turbulent flow of irrigating solution, resulting in corneal damage, inflammation of the endothelium and corneal edema.

In this study we want to evaluate the effect of the anterior capsule, gained by capsular rhexis, as a corneal shield during phacoemulsification on the corneal endothelium.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03855293
Study type Interventional
Source Vienna Institute for Research in Ocular Surgery
Contact
Status Completed
Phase N/A
Start date March 2, 2016
Completion date April 5, 2018

See also
  Status Clinical Trial Phase
Completed NCT04547036 - Changes in Corneal Endothelial Cell Density After Transscleral ab Interno Glaucoma Gel Stent Implantation
Completed NCT05529485 - Quantification of Factors Influencing Endothelial Damage During Phacoemulsification
Not yet recruiting NCT05194891 - Endothelial Changes in Pseudoexfoliation Syndrome
Recruiting NCT05587205 - Study to Assess Safety and Tolerability of EO2002 Phase 1